FDA approves Bendeka for CLL, NHL

FDA approved Bendeka bendamustine RTD ( EP-3102) from Teva Pharmaceutical Industries Inc. (NYSE:TEVA) and Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) to treat chronic lymphocytic leukemia and

Read the full 245 word article

How to gain access

Continue reading with a
two-week free trial.